However, when a subpopulation of 237 high grade basal-like breast cancer tumors were selected for the analysis, high TNK2 expression levels were significantly associated with poorer patient outcomes (p<0.01) (Figure 5B). This evidence concerns the gene TNK2 and breast cancer.